Potential Utility of Event-Free Survival (EFS) As Surrogate Endpoint for Overall Survival (OS) in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) after Autologous Stem Cell Transplantation (ASCT): A Subgroup Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Randomized Phase III Trial Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Li, Shen
  • Hay, Annette E
  • Crump, Michael
  • Anglin, Peter
  • Baetz, Tara
  • Meyer, Ralph
  • Keating, Armand
  • Robinson, Sue
  • Seftel, Matthew
  • Stelitano, Caterina
  • Djurfeldt, Marina S
  • Shepherd, Lois E
  • Chen, Bingshu E
  • Assouline, Sarit

publication date

  • December 7, 2017

published in